Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

80.42 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Lantheus to Present at the 2025 Truist Securities MedTech Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
What Does the Market Think About Lantheus Holdings?
Via Benzinga
Lantheus to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Holdings Inc (NASDAQ:LNTH) – An Undervalued Stock with Strong Fundamentals
Lantheus Holdings (LNTH) is an undervalued stock with strong profitability, financial health, and growth potential, trading below industry averages. A solid pick for value investors. 
Via Chartmill
Earnings Scheduled For May 7, 2025
Via Benzinga
Pharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore
These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next 
Via MarketBeat
Topics Earnings
Exposures Financial Product Safety
LNTH Q1 Earnings Call: Lantheus Lowers Outlook Amid Product Shifts and Divestitures
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $372.8 million. The company’s full-year revenue... 
Via StockStory
Lantheus Holdings, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - LNTH
From DJS Law Group
Via Business Wire
Why Lantheus (LNTH) Shares Are Getting Obliterated Today
Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell 22.2% in the afternoon session after the company reported weak first quarter 2025 results which included a significant miss on... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Sarepta Therapeutics, Mercury Systems, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Lantheus (NASDAQ:LNTH) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) fell short of the market’s revenue expectations in Q1 CY2025, with sales flat year on year at $372.8 million. The company’s full-year revenue... 
Via StockStory
Lantheus Reports First Quarter 2025 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Sale of SPECT Business to SHINE Technologies
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Earnings: What To Look For From LNTH
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be announcing earnings results tomorrow before market open. Here’s what you need to know. 
Via StockStory
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Lantheus Announces Alzheimer’s Disease Radiodiagnostic MK-6240 Meets Co-Primary Endpoints in Two Pivotal Studies
Company plans to file NDA in the third quarter of this year 
From Lantheus Holdings, Inc.
Via GlobeNewswire
In the world of growth stocks, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) shines as a value proposition.
LANTHEUS HOLDINGS INC could be undervalued. NASDAQ:LNTH is scoring impressively in terms of growth while demonstrating strong financials. On top of that, it remains attractively priced. 
Via Chartmill
Lantheus to Host First Quarter 2025 Earnings Conference Call and Webcast on May 7, 2025, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Q4 Earnings Outperformers: Hologic (NASDAQ:HOLX) And The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how medical devices & supplies - imaging, diagnostics stocks... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a growth stock which is not overvalued.
Discover LANTHEUS HOLDINGS INC, an undervalued growth gem. NASDAQ:LNTH is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing... 
Via Chartmill
3 Market-Beating Stocks to Consider Right Now
Companies that consistently increase their sales, margins, or returns on capital are usually rewarded with the best returns, and those that can do all three for years on end are almost always the... 
Via StockStory
Medical Devices & Supplies - Imaging, Diagnostics Stocks Q4 In Review: QuidelOrtho (NASDAQ:QDEL) Vs Peers
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including QuidelOrtho (NASDAQ:QDEL) and its... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Lantheus Completes Acquisition of Evergreen Theragnostics
From Lantheus Holdings, Inc.
Via GlobeNewswire
Q4 Earnings Review: Medical Devices & Supplies - Imaging, Diagnostics Stocks Led by GE HealthCare (NASDAQ:GEHC)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at GE HealthCare (NASDAQ:GEHC) and its peers. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
1 Healthcare Stock on Our Watchlist and 2 to Brush Off
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
For those who appreciate growth without the sticker shock, LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is worth considering.
Discover LANTHEUS HOLDINGS INC, an undervalued growth gem. NASDAQ:LNTH is shining in terms of growth metrics, and it's also displaying strong financial health and profitability, retaining an appealing... 
Via Chartmill
Q4 Earnings Highs And Lows: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - imaging, diagnostics industry, including Lantheus (NASDAQ:LNTH) and its... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily
3 Growth Stocks to Stash
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s... 
Via StockStory
Exposures COVID-19
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.